Monthly Archives: July 2012

Could not resist posting this ad I found in a local NYC Japanese magazine.  

Posted on by MP | Leave a comment

Anti-inflammatory utility of Boswellia serrata (frankincense)

Reading up on Boswellia serrata – this is a good starter article: http://www.altmedrev.com/publications/13/2/165.pdf “Boswellia serrata Description Boswellia serrata (frankincense) is a moderate-to-large branching tree (growing to a height of 12 feet) found in India, Northern Africa, and the Middle East. Strips of Boswellia bark are peeled away, yielding a gummy oleo-resin. Extracts of this gummy exudate have been traditionally used in the Ayurvedic system of medicine as an antiarthritic, astringent, stimulant, expectorant, and antiseptic.”  

Posted in Aging, Health, new treatments | Tagged , , , , , | Leave a comment

A role for vitamin D in the treatment of multiple sclerosis (MS)

This is such an important topic that I am posting the full-length article. On pubmed at http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2882221/?tool=pubmed. Neurology. 2010 June 8; 74(23): 1852–1859. doi:  10.1212/WNL.0b013e3181e1cec2 PMCID: PMC2882221 A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis J.M. Burton, MD, MSc, FRCPC, S. Kimball, MSc, MLT, R. Vieth, PhD, A. Bar-Or, MD, MSc, FRCPC, H.-M. Dosch, MD, PhD, R. Cheung, MSc, D. Gagne, C. D’Souza, PhD, M. Ursell, MS, MSc, FRCPC, and P. O’Connor, MS, MSc, FRCPC Author information ► Copyright and … Continue reading

More Galleries | Leave a comment

Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer’s disease: a randomized, double-blind, placebo-controlled, multicenter trial.

================================================   Nutr Metab (Lond). 2009 Aug 10;6:31. Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer’s disease: a randomized, double-blind, placebo-controlled, multicenter trial. Henderson ST, Vogel JL, Barr LJ, Garvin F, Jones JJ, Costantini LC. Source Accera, Inc,, 380 Interlocken Crescent, Suite 780, Broomfield, Colorado 80021, USA. shenderson@accerapharma.com. Abstract ABSTRACT: BACKGROUND: Alzheimer’s disease (AD) is characterized by early and region-specific declines in cerebral glucose metabolism. Ketone bodies are produced by the body during glucose deprivation and are metabolized by the brain. An … Continue reading

Posted in Aging, dietary, Health, metabolic, News, Psychiatry/Neurology | Tagged , , | Leave a comment

Anxiety, depression with glaucoma. Is isolation/loneliness the link?

Psychol Rep. 2010 Apr;106(2):343-57. Anxiety, depression, and quality of life in Turkish patients with glaucoma. Tastan S, Iyigun E, Bayer A, Acikel C. Source School of Nursing, Gülhane Military Medical Academy, Ankara, Turkey. Abstract The purpose was to investigate the relationship between anxiety, depression, and quality of life in patients with glaucoma. This case-control study was carried out with 121 participants with glaucoma (M age=64.2, SD=13.2; 68 women, 76.0% married) and 64 controls. The data were collected by using a data collection form involving questions … Continue reading

More Galleries | Leave a comment

Acquired synesthesia?

I came across this interesting article Colizoli O, Murre JM, and Rouw R (2012). Pseudo-Synesthesia through Reading Books with Colored Letters. PloS one, 7 (6) PMID: 22761905 posted at http://neuroskeptic.blogspot.com/2012/07/can-you-learn-to-be-synaesthetic.html I agree with the blogger and some real syn-esthetics who commented that it really has little to do with synesthesia, and more with mnemotechnic. I wonder if it could be used to learn Chinese characters.    

Posted in China, language, News, Psychiatry/Neurology, Uncategorized | Leave a comment